Kyoto, Japan

Rina Hashimoto

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rina Hashimoto: Innovator in siRNA Technology

Introduction

Rina Hashimoto is a prominent inventor based in Kyoto, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of small interfering RNA (siRNA) technology aimed at combating viral infections.

Latest Patents

Rina Hashimoto holds a patent for an innovative siRNA based on the RNA sequence of SARS-CoV-2. This patent, which includes a sense strand and an antisense strand, provides a method to suppress the proliferation of new coronaviruses. The sense strand comprises a target sequence of 19 to 23 bases, with specific requirements for the 5' terminal base and an overhang on the 3' terminal side. The antisense strand is complementary to the target sequence and also features an overhang. Notably, part of the target sequence encodes a signal peptide region of the spike protein of SARS-CoV-2.

Career Highlights

Throughout her career, Rina has worked with notable organizations, including Toagosei Company, Ltd. and Kyoto University. Her work has been instrumental in advancing the understanding and application of siRNA technology in medical research.

Collaborations

Rina has collaborated with esteemed colleagues such as Tetsuhiko Yoshida and Nahoko Baileykobayashi, contributing to the collective efforts in the field of virology and RNA research.

Conclusion

Rina Hashimoto's innovative work in siRNA technology represents a significant advancement in the fight against viral infections, particularly SARS-CoV-2. Her contributions continue to influence the field of biotechnology and inspire future research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…